News

Adial Pharmaceuticals to Present at the 2023 Jefferies Global Healthcare Conference on June 9th

CHARLOTTESVILLE, Va., June 01, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage…

2 years ago

Betterguards Wins Sports Technology Award for Best Injury Prevention and Recovery Technology; Launches Ankle Brace Sales in the U.S. Market

Sports Technology Awards winner brings game-changing innovation to U.S. athletes, backed by NBA stars Franz and Moe Wagner and industry…

2 years ago

Beckley Waves Establishes Ethics Council to Guide Industry Standards and Best Practices During Inaugural Summit of The World’s Leaders in Psychedelics

The New Ethics Council will Work Alongside Beckley Waves to set the Standard for Sustainable and Ethical Operations in the…

2 years ago

Solera Launches Streamlined Multi-Condition Management Platform for Employers to Increase Accountability While Reducing Costs

With Solera’s curated network of algorithmically matched digital health solutions, employers can reduce administrative burden and costs with a single…

2 years ago

ALR Technologies Announces Second Generation GluCurve Pet CGM for Diabetic Cats and Dogs

SINGAPORE, June 01, 2023 (GLOBE NEWSWIRE) -- ALR Technologies SG Ltd. (“ALRT”) (OTCQB:ALRTF), the diabetes management company, announces the issuance…

2 years ago

The International Myeloma Foundation (IMF) Honors 2023 Research Achievement Awardees, Dr. Maria-Victoria Mateos and Dr. Thomas Martin

LOS ANGELES, June 01, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) is proud to announce the recipients of…

2 years ago

Palisade Bio Promotes J.D. Finley to Chief Executive Officer

Carlsbad, CA, June 01, 2023 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a biopharmaceutical company advancing therapies…

2 years ago

Aleafia Health Announces Extension of Forbearance Under Loan Agreement With Senior Lender

TORONTO, June 01, 2023 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“Aleafia Health” or the “Company”) announces…

2 years ago

Mark Cuban Cost Plus Drug Company joins forces with Coherus to make YUSIMRY™, a HUMIRA® biosimilar, available to patients

–  YUSIMRY™ (adalimumab-aqvh) will be the first biologic product offered by the Mark Cuban Cost Plus Drug Company  – –  YUSIMRY will…

2 years ago

Culture Biosciences Establishes Advisory Board of Biotech and Biopharma Executives to Guide the Corporate Strategy and Accelerate Growth

Seasoned sector leaders will advise Culture’s leadership in customer intelligence and innovationSAN FRANCISCO, June 01, 2023 (GLOBE NEWSWIRE) -- Culture…

2 years ago